Zobrazeno 1 - 10
of 28
pro vyhledávání: '"E.Hugh Gerlach"'
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 17:307-311
The in vitro activity of E4868 was compared with that of ciprofloxacin and temafloxacin in a multicenter study. More than 90% of Enterobacteriaceae and 82% of the 651 isolates of Pseudomonas aeruginosa , as well as >95% of the oxacillin-susceptible s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5333041fc8289d8ef36d7b55261b28b6
https://doi.org/10.1016/0732-8893(93)90040-e
https://doi.org/10.1016/0732-8893(93)90040-e
Autor:
E.Hugh Gerlach, John A. Washington, Patrick R. Murray, Meridith E. Erwin, Helio S. Sader, Ronald N. Jones, Stephen D. Allen
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 17:143-150
A multicenter study was conducted in which the in vitro activity of cefpodoxime (the active metabolite of the prodrug ester cefpodoxime proxetil) was compared with those of cefixime, cefuroxime, cefaclor, cefadroxil, and clarithromycin against 5556 r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ea2bd12474fe2030928e9c20da7faac
https://doi.org/10.1016/0732-8893(93)90025-3
https://doi.org/10.1016/0732-8893(93)90025-3
Autor:
Stephen D. Allen, Meredith E. Erwin, Peter C. Fuchs, Patrick R. Murray, Ronald N. Jones, E.Hugh Gerlach
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 16:191-203
The in vitro activity of 13 β-lactam antibiotics against 1474 recent clinical isolates was evaluated in a multilaboratory study. The most active antibiotic tested in this study was imipenem (98.5% of the strains were susceptible), followed by ticarc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::047abb95c7c60779d2256d55d820cd45
https://doi.org/10.1016/0732-8893(93)90110-s
https://doi.org/10.1016/0732-8893(93)90110-s
Autor:
Patrick R. Murray, Ronald N. Jones, E.Hugh Gerlach, John A. Washington, Stephen D. Allen, Franklin P. Koontz, Michael A. Pfaller, Meridith E. Erwin
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 15:537-543
Cefdinir, a new oral cephalosporin, was compared to cefaclor, cefadroxil, cefixime, and cefuroxime against greater than 5000 recent aerobic clinical isolates. This multicenter study revealed broad-spectrum cefdinir activity against all Enterobacteria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb3f1b8d17cac58ce00007055588f045
https://doi.org/10.1016/0732-8893(92)90105-3
https://doi.org/10.1016/0732-8893(92)90105-3
Publikováno v:
Antimicrobic Newsletter. 8:31-35
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e276a1211170d9cf16a51242be1b548
https://doi.org/10.1016/0738-1751(92)90010-8
https://doi.org/10.1016/0738-1751(92)90010-8
Autor:
John A. Washington, E.Hugh Gerlach, Patrick R. Murray, James H. Jorgensen, Clyde Thornsberry, Gary V. Doern
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 14:485-493
A six-center collaborative study was performed with the aim of developing quality control test limits for both disk diffusion and broth microdilution susceptibility tests with Haemophilus influenzae ATCC 49247 using Haemophilus test medium. Quality c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04ab046fb7c30212fcc3a38ae67982aa
https://doi.org/10.1016/0732-8893(91)90004-y
https://doi.org/10.1016/0732-8893(91)90004-y
Autor:
Ronald N. Jones, Meridith E. Erwin, John A. Washington, Michael A. Pfaller, Frank Koontz, C C Knapp, Patrick R. Murray, E.Hugh Gerlach
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 14:383-388
Cefixime was tested in a multilaboratory study to establish susceptibility testing interpretive criteria and quality control (QC) guidelines for Neisseria gonorrhoeae. Interpretive criteria were established by using triplicate testing of 102 represen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d964e8afc2e3009084dee0e218cd36b3
https://doi.org/10.1016/0732-8893(91)90065-n
https://doi.org/10.1016/0732-8893(91)90065-n
Autor:
Peter C. Fuchs, Clyde Thornsberry, E.Hugh Gerlach, Ronald N. Jones, John A. Washington, Patrick R. Murray, Thomas L. Gavan
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 13:499-507
Cefotaxime, cefoxitin, ceftazidime, and cefuroxime were tested in a multicenter study to establish susceptibility testing criteria and quality control guidelines for Neisseria gonorrhoeae. Interpretive criteria were established by using triplicate te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcc551bed6667898b4f5457fc0456a32
https://doi.org/10.1016/0732-8893(90)90082-7
https://doi.org/10.1016/0732-8893(90)90082-7
Autor:
Ronald N. Jones, E.Hugh Gerlach, Kenneth E. Aldridge, Peter C. Fuchs, Stephen D. Allen, Steven A. Marshall
Publikováno v:
Diagnostic microbiology and infectious disease. 21(3)
Piperacillin combined with tazobactam at a fixed concentration (4 micrograms/ml) and a ratio (8:1) was tested against 5,029 aerobic isolates and 447 fastidious organisms, including anaerobes. Among the Enterobacteriaceae,95% inhibition was shared onl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f1f3feb213c6ad0160655417dc104be
https://pubmed.ncbi.nlm.nih.gov/7648836
https://pubmed.ncbi.nlm.nih.gov/7648836
Autor:
William W. Hoover, George M. Eliopoulos, Ronald N. Jones, Michael A. Pfaller, E.Hugh Gerlach, Daryl J. Hoban
Publikováno v:
Diagnostic microbiology and infectious disease. 16(2)
Rifaximin, a rifamycin derivative, was evaluated in vitro to assess its spectrum and potency against a wide variety of bacteria, yeasts, viruses, and parasites. High concentrations of rifaximin were often used to reflect topically achieved levels sin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e26cacfc8767014f4b403b95b179117
https://pubmed.ncbi.nlm.nih.gov/8385592
https://pubmed.ncbi.nlm.nih.gov/8385592